JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
SHISX
Price
$66.86
Change
-$0.42 (-0.62%)
Updated
Feb 21 closing price
Net Assets
7.43B
Ad is loading...

JNGLX vs SHISX

Header iconJNGLX vs SHISX Comparison
Open Charts JNGLX vs SHISXBanner chart's image
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
BlackRock Health Sciences Opps Svc
Price$66.86
Change-$0.42 (-0.62%)
VolumeN/A
Net Assets7.43B
JNGLX vs SHISX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JNGLX vs. SHISX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNGLX is a Buy and SHISX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SHISX has more cash in the bank: 7.44B vs. JNGLX (5B). SHISX pays higher dividends than JNGLX: SHISX (0.18) vs JNGLX (0.12). JNGLX was incepted earlier than SHISX: JNGLX (26 years) vs SHISX (20 years). JNGLX is a more actively managed with annual turnover of: 34.00 vs. SHISX (29.00). JNGLX has a lower initial minimum investment than SHISX: JNGLX (2500) vs SHISX (5000). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. SHISX (-5.85). JNGLX return over 5 years is better than : 17.54 vs. SHISX (0.62).
JNGLXSHISXJNGLX / SHISX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years20 years-
Gain YTD5.4216.44884%
Front LoadN/AN/A-
Min. Initial Investment2500500050%
Min. Initial Investment IRAN/AN/A-
Net Assets5B7.44B67%
Annual Yield % from dividends0.120.1867%
Returns for 1 year-3.67-5.8563%
Returns for 3 years15.970.951,682%
Returns for 5 years17.540.622,840%
Returns for 10 years29.2528.28103%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P